Ruth Ann Marrie1, Lawrence Elliott2, James Marriott2, Michael Cossoy2, James Blanchard2, Aruni Tennakoon2, Nancy Yu2. 1. From the Departments of Internal Medicine (R.A.M., J.M., M.C.) and Community Health Sciences (R.A.M., L.E., J.B., A.T., N.Y.), University of Manitoba, Winnipeg; and Epidemiology and Surveillance (N.Y.), Public Health and Primary Care Division, Manitoba Health, Winnipeg, Manitoba, Canada. rmarrie@hsc.mb.ca. 2. From the Departments of Internal Medicine (R.A.M., J.M., M.C.) and Community Health Sciences (R.A.M., L.E., J.B., A.T., N.Y.), University of Manitoba, Winnipeg; and Epidemiology and Surveillance (N.Y.), Public Health and Primary Care Division, Manitoba Health, Winnipeg, Manitoba, Canada.
Abstract
OBJECTIVE: We aimed to describe hospitalizations in the multiple sclerosis (MS) population, and to evaluate temporal trends in hospitalizations in the MS population compared to the general population. METHODS: Using population-based administrative data, we identified 5,797 persons with MS and a matched general population cohort of 28,769 persons. Using general linear models, we evaluated temporal trends in hospitalization rates and length of stay in the 2 populations over the period 1984-2011. RESULTS: In 1984 the hospitalization rate was 35 per 100 person-years in the MS population and 10.5 in the matched population (relative risk [RR] 3.33; 95% confidence interval: 1.67-6.64). Over the study period hospitalizations declined 75% in the MS population but only 41% in the matched population. The proportion of hospitalizations due to MS declined substantially from 43.4% in 1984 to 7.8% in 2011. The 3 most common non-MS-related reasons for admission in the MS population were diseases of the digestive, genitourinary, and circulatory systems. Admissions for bacterial pneumonia, influenza, urinary tract infections, and pressure ulcers occurred more often in the MS population than in the general population, while admissions for circulatory system disease and neoplasms occurred less often. Older age, male sex, and lower socioeconomic status were associated with increased hospitalization rates for non-MS-related reasons. CONCLUSIONS: Although hospitalization rates have declined dramatically in the MS population over the last quarter century, they remain higher than in the general population. Admissions for MS-related reasons now constitute only a small proportion of the reasons for hospitalization.
OBJECTIVE: We aimed to describe hospitalizations in the multiple sclerosis (MS) population, and to evaluate temporal trends in hospitalizations in the MS population compared to the general population. METHODS: Using population-based administrative data, we identified 5,797 persons with MS and a matched general population cohort of 28,769 persons. Using general linear models, we evaluated temporal trends in hospitalization rates and length of stay in the 2 populations over the period 1984-2011. RESULTS: In 1984 the hospitalization rate was 35 per 100 person-years in the MS population and 10.5 in the matched population (relative risk [RR] 3.33; 95% confidence interval: 1.67-6.64). Over the study period hospitalizations declined 75% in the MS population but only 41% in the matched population. The proportion of hospitalizations due to MS declined substantially from 43.4% in 1984 to 7.8% in 2011. The 3 most common non-MS-related reasons for admission in the MS population were diseases of the digestive, genitourinary, and circulatory systems. Admissions for bacterial pneumonia, influenza, urinary tract infections, and pressure ulcers occurred more often in the MS population than in the general population, while admissions for circulatory system disease and neoplasms occurred less often. Older age, male sex, and lower socioeconomic status were associated with increased hospitalization rates for non-MS-related reasons. CONCLUSIONS: Although hospitalization rates have declined dramatically in the MS population over the last quarter century, they remain higher than in the general population. Admissions for MS-related reasons now constitute only a small proportion of the reasons for hospitalization.
Authors: Ruth Ann Marrie; Bo N Yu; Stella Leung; Lawrence Elliott; Patricia Caetano; Sharon Warren; Christina Wolfson; Scott B Patten; Lawrence W Svenson; Helen Tremlett; John Fisk; James F Blanchard Journal: Mult Scler Relat Disord Date: 2013-04-02 Impact factor: 4.339
Authors: Shivanand P Lad; Christopher H Chapman; Michael Vaninetti; Lawrence Steinman; Ari Green; Maxwell Boakye Journal: Neuroepidemiology Date: 2010-06-15 Impact factor: 3.282
Authors: Richard A Rudick; William H Stuart; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Ernst-Wilhelm Radue; Fred D Lublin; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara; Alfred W Sandrock Journal: N Engl J Med Date: 2006-03-02 Impact factor: 91.245
Authors: Norrina B Allen; Judith H Lichtman; Hillel W Cohen; Jing Fang; Lawrence M Brass; Michael H Alderman Journal: Neuroepidemiology Date: 2008-04-25 Impact factor: 3.282
Authors: Nana Amankwah; Ruth Ann Marrie; Christina Bancej; Rochelle Garner; Douglas G Manuel; Ron Wall; Philippe Finès; Julie Bernier; Karen Tu; Kim Reimer Journal: Health Promot Chronic Dis Prev Can Date: 2017-02 Impact factor: 3.240
Authors: Tingting Zhang; Andrew R Zullo; Theresa I Shireman; Yoojin Lee; Vincent Mor; Qing Liu; Kevin W McConeghy; Lori Daiello; Douglas P Kiel; Sarah D Berry Journal: Disabil Health J Date: 2018-03-21 Impact factor: 2.554
Authors: Charles N Bernstein; Carol A Hitchon; Randy Walld; James M Bolton; Lisa M Lix; Renée El-Gabalawy; Jitender Sareen; Alexander Singer; Alan Katz; James Marriott; John D Fisk; Scott B Patten; Ruth Ann Marrie Journal: Inflamm Bowel Dis Date: 2021-08-19 Impact factor: 5.325
Authors: Raffaella Greco; Tobias Alexander; Joachim Burman; Nicoletta Del Papa; Jeska de Vries-Bouwstra; Dominique Farge; Jörg Henes; Majid Kazmi; Kirill Kirgizov; Paolo A Muraro; Elena Ricart; Montserrat Rovira; Riccardo Saccardi; Basil Sharrack; Emilian Snarski; Barbara Withers; Helen Jessop; Claudia Boglione; Ellen Kramer; Manuela Badoglio; Myriam Labopin; Kim Orchard; Selim Corbacioglu; Per Ljungman; Malgorzata Mikulska; Rafael De la Camara; John A Snowden Journal: Bone Marrow Transplant Date: 2021-05-24 Impact factor: 5.483